Interferon (IFN)-ß1a and IFN-ß1b Block IFN-?-Induced Disintegration of Endothelial Junction Integrity and Barrier

References

• Ali J., Liao F., Martens E., and Muller W.A. (1997) Vascular endothelial cadherin (VE-cadherin): Cloning and role in endothelial cell-cell adhesion. Microcirculation, 4, 267–277.
   Google Scholar
• Allport J.R., Ding H., Collins T., Gerritsen M.E., and Luscinskas F.W. (1997) Endothelial-dependent mechanisms regulate leukocyte transmigration: Aprocessinvolving the proteosome and disruption of the vascular endothelialcadherin complex at endothelial cell-to-cell junctions. Journal of Experimen­ tal Medicine, 186, 517–527.
   Google Scholar
• Althaus H.H., Kloppner S., Schmidt-Schultz T., and Schwartz P. (1992) Nerve growth factor induces proliferation and enhances fiber regeneration in oligodendrocytes isolated from adult pig brain. Neuroscience Letters, 135, 219– 223.
   Google Scholar
• Anderson J.M., and Van Itallie C.M. (1995) Tight junctions and the molecular basis for regulation of paracellular permeability. American Journal of Pathol­ ogy, 269, G467–G475.
   Google Scholar
• Boutros I., Croze E., and Yong V.W. (1997) Interferon-Î2 is a potent promoter of nerve growth factor production by astrocytes. Journal of Neurochemistry, 69, 939–946.
   Google Scholar
• Breviario F., Caveda L., Corada M., Martin-Padura I., et al. (1995) Func­ tional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endothelium-specific cadherin. Arteriosclerosis Thrombosis and Vascular Biology, 15, 1229–1239.
   PubMed Web of Science ®Google Scholar
• Brosnan C.F., and Raine C.S. (1996). Mechanisms of immune injury in multiple sclerosis. Brain Pathology, 6, 243–257.
   PubMed Web of Science ®Google Scholar
• Burns A.R., Bowden R.A., MacDonell S.D., Walker D.C., Odebunmi T.O., Donnachie E.M., Simon S.I., Entman M.L., and Smith C.W. (2000) Analysis of tight junctions during neutrophil transendothelial migration. Journal of Cell Science, 113(Pt 1), 45–47.
   Web of Science ®Google Scholar
• Burns A.R., Walker D.C., Brown E.S., ThurmonL.T., Bowden R.A., Keese C.R., Simon S.I., Entman M.L., and Smith C.W. (1997) Neutrophil transendothe­ lial migration is independent of tight junctions and occurs preferentially at tricellular corners. Journal of Immunology, 159, 2893–2903.
   PubMed Web of Science ®Google Scholar
• Chofflon M., Juillard C, Juillard P., Gauthier G., and Grau G.E. (1992) Tumor necrosis factor alpha production as a possible predictor of relapse in patients with multiple sclerosis. European Cytokine Network, 3, 523–531.
   PubMedGoogle Scholar
• Corada M., Mariotti M., Thurston G., Smith K., Kunkel R., Brockhaus M., Lampugnani M.G., Martin-Padura I., Stoppacciaro A., Ruco L., McDonald D.M., Ward P.A., and Dejana E. (1999) Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proceedings of the National Academy of Sciences of the United States of America, 96, 9815–9820.
   PubMed Web of Science ®Google Scholar
• Darnell J.E. Jr., Kerr I.M., and Stark G.R. (1994) JAK-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science, 264, 1415–1421.
   PubMed Web of Science ®Google Scholar
• De Maeyer E., and De Maeyer-Guignard J. (1994) Interferons. In The Cy­ tokine Handbook, 2nd ed. (ed. A.W. Thomason), San Diego, Academic Press, pp. 265–288.
   Google Scholar
• Del Maschio A., Zanetti A., Corada M., Rival Y., Ruco L., Lampugnani M.G., and Dejana E. (1996) Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions. Journal of Cell Biology, 135,497–510.
   PubMed Web of Science ®Google Scholar
• Dhib-Jalbut S. (1997) Mechanisms of interferon beta action in multiple sclerosis. Multiple Sclerosis, 3, 397–401.
   PubMed Web of Science ®Google Scholar
• Dhib-Jalbut S., Jiang H., and Williams G.J. (1996) The effect of interferon beta-1b on lymphocyte-endothelial adhesion. Journal of Neuroimmunology, 71, 215–222.
   PubMed Web of Science ®Google Scholar
• Fujimoto K. (1995) Freeze-fracture replica electron microscopy combined with SDS digestion for cytochemical labeling of integral membrane proteins: Ap­ plication to the immunogold labeling of intercellular junctional complexes. Journal of Cell Science, 108 (Pt 11), 3443–3449.
   PubMedGoogle Scholar
• Furuse M., Hirase T., Itoh M., Nagafuchi A., Yonemura S., Tsukita S., and Tsukita S. (1993) Occludin: A novel integral membrane protein localizing at tight junctions. Journal of Cell Biology, 123, 1777–1788.
   PubMed Web of Science ®Google Scholar
• Furuse M., Fujimoto K., Sato N., Hirase T., Tsukita S., and Tsukita S. (1996) Overexpression of occludin, a tight junction-associated integral membrane protein, induces the formation of intracellular multilamellar bodies bearing tight junction-like structures. Journal of Cell Science, 109, 429–435.
   PubMed Web of Science ®Google Scholar
• Haselton F.R., and Heimark R.L. (1997) Role of cadherins 5 and 13 in the aortic endothelial barrier. Journal of Cellular Physiology, 171, 243–251.
   PubMed Web of Science ®Google Scholar
• Hordijk PL., Anthony E., Mul F.P., Rientsma R., Oomen L.C., and Roos D. (1999) Vascular-endothelial-cadherin modulates endothelial monolayer per­ meability. Journal of Cell Science, 112, 1915–1923.
   PubMed Web of Science ®Google Scholar
• Hummel V., Kallmann B.A., Wagner S., Fuller T., Bayas A., Tonn J.C., Benveniste E.N., Toyka K.V., and Rieckmann P. (2001) Production of MMPs in human cerebral endothelial cells and their role in shedding adhesion molecules. Journal of Neuropathology and Experimental Neurology, 60,320–327.
   PubMed Web of Science ®Google Scholar
• IFNB Multiple Sclerosis Study Group. (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicen­ tre, randomized, double-blind, placebo-controlled trial. Neurology, 43, 655–661.
   PubMed Web of Science ®Google Scholar
• Jacobs L.D., Cookfair D.L., Rudick R.A., Herndon R.M., Richert J.R., Salazar A.M., Fischer J.S., Goodkin D.E., Granger C.V., Simon J.H.,
   Google Scholar
• Alam J.J., Bartoszak D.M., Bourdette D.N., Braiman J., Brownscheidle CM., Coats M.E., Cohan S.L., Dougherty D.S., Kinkel R.P., Mass M.K., MunschauerF.E. 3rd, Priore R.L., Pullicino P.M., Scherokman B.J., Whitham R.H., et al. (1996). Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Annals of Neurology, 39, 285–294.
   PubMed Web of Science ®Google Scholar
• Jiang H., Milo R., Swoveland P., Johnson K.P, Panitch H., and Dhib-Jalbut S. (1995) Interferon /?-1b reduces interferon y-induced antigen-presenting capacity of human glial and B cells. Journal of Neuroimmunology, 61, 17– 25.
   Google Scholar
• Kevil C. G., Payne D. K., Mire E., and Alexander J. S. (1998) Vascular perme-ability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins. Journal of Biological Chemistry, 273, 15099–15103.
   PubMed Web of Science ®Google Scholar
• Lampugnani M.G., Resnati M., Raiteri M., Pigott R., Pisacane A., Houen G., Ruco L.P, and Dejana E. (1992) A novel endothelial-specific membrane protein is a marker of cell-cell contacts. Journal of Cell Biology, 118, 1511– 1522.
   Google Scholar
• Minagar A., Jy W., Jimenez J.J., Sheremata W.A., Mauro L.M., Mao W.W., Horstman L.L., and Ahn Y.S. (2001) Elevated plasma endothelial microparticles in multiple sclerosis. Neurology, 56, 1319–1324.
   PubMed Web of Science ®Google Scholar
• Minagar A., Ostanin D., Long A.C., Jennings M., Kelley R.E., Sasaki M., and Alexander J.S. (2003) Serum from multiple sclerosis patients down-regulates occludin and VE-cadherin expression in cultured endothelial cells. Multiple Sclerosis, 9, 235–238.
   PubMed Web of Science ®Google Scholar
• Oshima T., Laroux F.S., Coe L.L., Morise Z., Kawachi S., Bauer P., Grisham M.B., Specian R.D., Carter P., Jennings S., Granger D.N., Joh T., and Alexander J.S. (2001) Interferon-gamma and interleukin-10 reciprocally regulate endothelial junction integrity and barrier function. Microvascular Research, 61, 130–143.
   PubMed Web of Science ®Google Scholar
• Panitch H.A., Hirsch R.L., Schindler J., and Johnson K.P. (1987) Treatment of multiple sclerosis patients with gamma interferon: Exacerbations associated with activation of immune function. Neurology, 37, 1097–1102.
   PubMed Web of Science ®Google Scholar
• Rieckmann P., Michel U., Albrecht M., Bruck W., Wockel L., and Felgenhauer K. (1995) Cerebral endothelial cells are a major source for soluble intercellular adhesion molecule-1 in the human central nervous system. Neuroscience Letters, 186, 61–64.
   PubMed Web of Science ®Google Scholar
• Satoh J.-I., Paty D.W., and Kim S.U. (1995) Differential effects of beta and gamma interferons on expression of major histocompatibility complex antigens and intracellular adhesion molecule-1 in cultured fetal human astrocytes. Neurology, 45, 367–373.
   PubMed Web of Science ®Google Scholar
• Springer T.A. (1994) Traffic signals for lymphocyte recirculation and leukocyte migration: The multistep paradigm. Cell, 76, 301–314.
   PubMed Web of Science ®Google Scholar
• Yilmaz A., Bieler G., Spertini O., Lejeune F.J., and Ruegg C. (1998) Pulse treatment of human vascular endothelial cells with high concentrations of tumor necrosis factor and interferon-gamma results in simultaneous synergistic and reversible effects on proliferation and morphology. International Journal of Cancer, 77, 592–599.
   PubMed Web of Science ®Google Scholar
• Yong V.W., Chabot S., Stuve O., and Williams G. (1998) Interferon beta in the treatment of multiple sclerosis: Mechanisms of action. Neurology, 51, 682–689.
   PubMed Web of Science ®Google Scholar
• Yoshida N., Granger D.N., Anderson D.C., Rothlein R., Lane C, and Kvietys PR. (1992) Anoxia/reoxygenation-induced neutrophil adherence to cultured endothelial cells. American Journal of Physiology, 262, H1891–H1898.
   PubMed Web of Science ®Google Scholar
• Waubant E., Goodkin D.E., Gee L., Bacchetti P., Sloan R., Stewart T, et al. (1999) Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology, 53, 1397–1401.
   PubMed Web of Science ®Google Scholar
• Waubant E., Goodkin D., Bostrom A., Bacchetti P., Hietpas J., Lindberg R., and Leppert D. (2003) IFN-/J lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS. Neurology, 60, 52–57.
   PubMed Web of Science ®Google Scholar